Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens
Clinical trial NCT01365507 · COMPLETED
Trial details
- NCT number
- NCT01365507
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2012-04-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.